Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications - Clinical Therapeutics
Design and validation of a histological scoring system for nonalcoholic fatty liver disease - Kleiner - 2005 - Hepatology - Wiley Online Library
Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease Ting Soon GS, Wee A - Indian J Pathol Microbiol
Liver Pathology: Steatohepatitis | Liver Fellow Network
NASH clinical research network scoring system. | Download Table
Non-Alcoholic Steatohepatitis (NASH) information for healthcare providers | Labcorp
Table 1 from Pathology of Non-Alcoholic Fatty Liver Disease | Semantic Scholar
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease - Journal of Hepatology
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease - Gastroenterology
Nonalcoholic fatty liver disease: Definitions, risk factors, and workup - Puri - 2012 - Clinical Liver Disease - Wiley Online Library
NASH/NAFLD Clinical Research Network scoring system definition and... | Download Table
NASH model evaluated by NASH Research Network Scoring System... | Download Scientific Diagram
Common endpoints of clinical trials in NAFLD/NASH | Download Table
Liver Pathology: Steatohepatitis | Liver Fellow Network
Life | Free Full-Text | Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome | HTML
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
NAFLD SCORE
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management - ScienceDirect
NASH CRN NAFLD activity scoring system | Download Table
NASH Clinical Research Network histological scoring system | Download Table
DDTBMQ000105 LOI Submission NASH
Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Management of non-alcoholic fatty liver disease | The BMJ
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design - ScienceDirect
NASH CRN NAFLD activity scoring system | Download Table
